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Abstract 
In the 12-day-old rat cochlea, the synthesis of inositol phosphates (IPS) can be activated via M3 
cholinoceptors. This stimulation is blocked by ototoxins (mercury, ethacrynate, cisplatin, neomycin), drugs 
with side effects that lead to damage of hair cells and strial cells. As these toxic effects can be reversed 
in vivo by thiol molecules, we investigated whether modifications of thiol compounds could be involved in 
ototoxin-induced inhibition of the IP turnover in the cochlea. For this purpose, we assessed whether the 
sulphhydryl-modifying reagents N-ethylmaleimide and cadmium modify the carbachol-stimulated formation of 
IPS in the 12-day-old rat cochlea. Both molecules inhibit the carbachol effect on a dose-dependent way 
without altering the basal metabolism of IPS. As cadmium may block some calcium channels, the effect of 
verapamil, another calcium channel antagonist, was tested. Verapamil (1 - 50 pM) does not alter carbachol- 
evoked IP formation, suggesting that the inhibitory effect of cadmium is not due to a calcium influx block. 
Binding experiments with the muscarinic ligand quinuclidinyl benzylate (QNB) showed that the sulphhydryl- 
modifying reagents do not displace QNB from binding sites. Combining ototoxins and reagents shows that 
N-ethylmaleimide acts synergistically with all ototoxins but ethacrynate while cadmium does so only with 
mercury. Both N-ethylmaleimide and cadmium have additive effects with ethacrynate. As a supplement, 
disulphide bond-modifying agents do not alter the carbachol-enhanced metabolism of IPS. These results 
suggest that molecules having thiol-modifying properties inhibit the carbachol-induced turnover of IPS without 
acting at the muscarinic sites. Since thiol modifiers and ethacrynate share similar features in both QNB 
binding and IP response it is hypothesized that they strike common targets, possibly G proteins. 
Introduction 
The ototoxins are drugs belonging to several biochemical classes: 
mercurials, anti-cancer drugs, ‘loop’ diuretics and aminoglycoside 
antibiotics. A feature that they have in common is that they provoke 
damage to cells in the cochlea. In this structure, their main targets are 
the strial cells of the lateral wall and the outer hair cells (OHCs) in 
the organ of Corti (for reviews see Hawkins, 1976; Rybak, 1986; 
Huang and Schacht, 1989). The mechanisms underlying ototoxicity 
are very complex and are currently the subject of considerable 
investigation. Recently, the blockage of the muscarinic receptor-linked 
inositol phosphate (IP) signalling pathway (Guiramand et al., 1990; 
Bartolami et al., 1990; Niedzielsky et al., 1992) by various ototoxins 
(mercuric chloride, cisplatin, ethacrynate and neomycin) has been 
reported in the rat cochlea (Bartolami et al., 1993). In addition, binding 
studies showed that all ototoxins except ethacryanate interact with 
muscarinic binding sites (S.Bartolami, M.Planche and R.Pujo1, sub- 
mitted for publication), and Schacht (1976, 1986) established that 
aminoglycosides interact with the phosphoinositide cycle by complexing 
phosphatidylinositol4,5-bisphosphate. It is, then, possible that ototoxins 
reduce the carbachol-activated IP response in several ways, including 
binding to precursors and occupancy of muscarinic sites. 
Most ototoxins are also nephrotoxic, indicating that pathological 
processes in the cochlea and in the kidney could be the same. In this 
respect, ethacrynate, which is a sulphhydryl-reactive diuretic (Koechel 
and Cafruny, 1975), has been proposed to cause nephrotoxicity via 
an alkylating step (Koechel et al., 1984). The nephrotoxicity provoked 
by cisplatin can be prevented by sulphhydryl molecules including the 
thiol metabolite WR1065 of the prodrug WR2721 (Treskes et al.,  
1992a), diethyldithiocarbamate (Borch and Pleasants, 1979), 
4-methylthiobenzoic acid (Boogaard et al . ,  1991), N-benzyl-D- 
glucamine dithiocarbamate (Kiyozumi er al . ,  1991) and glutathione 
(Zunino et al . ,  1989). Moreover, similar observations are reported in 
the inner ear: the toxic metabolite of the aminoglycoside gentamicin 
(Huang and Schacht, 1990; Cram el al., 1992), which promotes OHC 
death in vitro, is inactivated by glutathione (Garetz and Schacht, 1992). 
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Conversely, depletion of glutathione potentiates the ototoxicity induced 
by ethacrynate and the aminoglycoside kanamycin (Hoffman et al., 
1987, 1988). Lastly, mercuric chloride, which inhibits the carbachol- 
evoked formation of IPS in the rat cochlea (Bartolami et al., 1993), 
is a well known sulphhydryl-modifying reagent (Vallee and Ulmer, 
1972). 
These observations indicate the existence of interactions between 
ototoxins and sulphhydryl groupbearing compounds in both ototoxicity 
and nephrotoxicity. A similar conclusion can be reached with cisplatin 
in other systems. For example, cisplatin-induced DNA platination is 
blocked by WR1065 and diethyldithiocarbamate (Treskes et al., 
1992b), there are strong interactions between cisplatin and the 
sulphhydryl residue cysteine (Lempers and Reedijk, 1990), and the 
resistance of cancer cell lines to cisplatin correlates with an increase 
in the cellular level of glutathione (Godwin et al., 1992). 
It appears, then, that ototoxins such as cisplatin, mercury and 
ethacrynate interact with molecules bearing thiol groups. The fact that 
ototoxins may inhibit carbachol-stimulated IP formation by acting on 
sulphhydryl group-bearing proteins is therefore a tempting hypothesis. 
The aim of this report was to assess, in the cochlea, the sensitivity 
of the carbachol-induced metabolism of Ips to molecules known to react 
with sulphhydryl groups. For this purpose, we studied the effect of 
N-ethylmaleimide and cadmium on the metabolism of IPS coupled to 
muscarinic receptors in the 12-day-old rat cochlea. This stage of 
maturation was chosen firstly because the carbachol-elicited turnover 
of IPS is maximal at day 12 (Bartolami et al., 1990) and secondly 
because this age is within the critical period of enhanced susceptibility 
to ototoxicity (for review see Pujol, 1986). N-ethylmaleimide was 
selected both for its high potency as a sulphydryl-modifying reagent 
and for its alkylating property, similar to that of ethacrynate, and 
cadmium was chosen because, besides being a sulphhydryl modifier 
(Vallee and Ulmer, 1972; Bruggeman et al., 1992) and a calcium 
channel blocker (Tsien, 1983), it is also both a nephrotoxic compound 
(Nicholson et al., 1983) and a heavy metal like cisplatin and mercury. 
Preliminary results have been presented (Bartolami et al., 1992a). 
Materials and methods 
Reagents 
My0-[2-(~H)]inositol (specific activity 17.0 Ci/mmol) was purchased 
from Dositek (France) and tritiated quiniclidinyl benzylate (QNB, 
specific activity 45.4 Ci/mmol) from New England Nuclear. Atropine, 
carbachol, N-ethylmaleimide (NEM), neomycin, ethacrynic acid, 
cisplatin (cis-diamminedichloroplatinum 11), DL-dithiothreitol, 
verapamil and 5 3  '-dithio-bis-2-nitrobenzoic acid (DTNB) were 
obtained from Sigma. All other compounds were of analytical grade. 
Dissection of cochleas 
Twelve-day-old Wistar rats were obtained from the Centre d'klevage 
de la FacultC de Pharmacie (Montpellier, France) and s t u ~ e d  before 
decapitation. The cochleas were dissected from temporal bones, the 
otic capsules and the stria vascularis were removed with the aid of 
a high-quality dissecting microscope. Under microscopic observation, 
the various regions of the cochlea including the organ of Corti and 
the spiral ganglion were easily recognizable, enabling the verification 
of morphological integrity of each cochlea. Damaged cochleas were 
discarded. The cochlear tissues were collected in Krebs - Ringer buffer 
(in mM: 125 NaCl, 3.5 KCl, 1.25 KH,PO,, 1.2 MgS04, 1.5 CaCl,, 
25 NaHCO, and 10 glucose). The dissected cochleas (consisting of 
the organ of Corti, the spiral ganglion and the modiolus) were 
maintained in buffer equilibrated to pH 7.4 by bubbling with a mixture 
of 0, 95 % and CO, 5 % (vol/vol) throughout the experiment. 
Labelling of cochlear tissues 
Incorporation of [3H]inositol into the cochleas was carried out at 37°C 
for 75 min in Krebs-Ringer buffer containing 1 mM cytidine and 
10.8 pCi/ml my0-[2-~H]inositol. Afterwards, the cochleas were 
washed four times with Krebs-Ringer buffer and then individually 
distributed in test tubes containing 500 pl buffer. The tubes were 
transferred to a water bath thermostatically maintained at 37°C and 
continuously bubbled with the O,/CO, mixture. 
Stimulation of synthesis of IPS and purification of PHIIPS 
LiCl(10 mM) and the toxic agents neomycin, ethyacrynate, mercuric 
chloride, cisplatin and/or sulphhydryl-modifying reagents NEM and 
cadmium chloride (where applicable) were added 15 min prior to 
stimulation by carbachol(1 mM). The muscarinic agonist was allowed 
to react for 20 min. The reaction was stopped by the application of 
50 plltube of perchloric acid (72%) and by placing the tubes on ice. 
Cochlear homogenates, obtained by sonication, were centrifuged at 
2000 g for 5 min. The supernants containing the [,HIIPS were 
neutralized with 1.5 M KOH/0.075 M HEPES. After separation by 
anion-exchange chromatography, the [3H]IPs formed were measured 
in each cochlea as previously described (Guiramand et al., 1990). The 
basal IP metabolism (basal control) was determined according to this 
procedure, in the absence of carbachol, ototoxins and sulphhydryl 
modifiers. The stimulated control level of IP formation was determined 
with carbachol (1 mM) in the absence of ototoxins and sulphhydryl 
modifiers. Since cadmium is also a calcium channel antagonist (Tsien, 
1983), we tested the effect of verapamil, a calcium channel blocker 
on the carbachol-induced formation of IPS. Verapamil was applied 
together with lithium before the addition of carbachol. In addition, this 
study focusing on alterations of sulphate moieties was supplemented 
by assessment of the effects of DL-dithiothreitol and DTNB on the 
carbachol-induced IP responses. These molecules are disulphide bond 
modifiers. 
Membrane preparation for binding experiments 
Cochleas, dissected as indicated above, were washed four times with 
phosphate-buffered saline, pH 7.4 (PBS; 50 mh4 Na2HP0,, 50 mM 
KH2P04, 125 mM NaCl) and then squashed into PBS with an all-glass 
homogenizer at the concentration of six cochleas/ml. The bony 
fragments were removed by centrifugation at 150 g for 5 min, and the 
supernatant containing the cochlear membranes was stored at -70°C 
before use. 
PHlQNB binding assays 
Aliquots of the membrane preparation (320 pl) were mixed with 40 pl 
PBS and [3H]QNB at 0.08 nM and then incubated at 25°C for 
90 min. Preliminary results have shown that at 0.08 nM the QNB 
binding is close to saturation in this preparation (Bartolami et al., 
1992b). The binding reaction was stopped by filtration of the samples 
on Whatman GF/B filters and washing the filters with 3 X 4 ml PBS 
at 4°C. The amount of [3H]QNB retained per filter was measured by 
liquid scintillation counting. This procedure allows the determination 
of the total amount of bound QNB. In order to measure the non-specific 
binding, 1 pM atropine was added to the incubation medium. The 
amount of specifically bound QNB was obtained by subtracting the 
value of the non-specific binding from the total binding. Trials of 
displacement of the bound QNB were conducted by adding the 
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FIG. 1. Dosedependent effects of N-ethylmaleimide and cadmium chloride on IP synthesis. Right, effects of NEM; left, effects of cadmium chloride. The amount 
of IPS formed in the presence of NEM or cadmium was measured in individual cochleas that were either stimulated by 1 mM carbachol or non-stimulated. The 
data are means f SEM of 6- 12 individual replications. The basal IP synthesis is 60 f 4 dpm IPS x 1000/d.p.m. inositol and the carbachol(1 mM)-stimulated 
control level is 324 f 20 d.p.m. IPS X 1000/d.p.m. inositol. When error bar is not indicated, the width of the error bar is smaller than the thickness of the 
symbols. Carb, carbachol. 
sulphhydryl-modifying reagents cadmium chloride and NEM to the 
medium. The results of the binding assays were normalized to the 
amount of protein present in the membrane preparation, which was 
measured according to Lowry et al. (1951). 
Data expression and statistical analysis 
Data are expressed either as percentage of the level of specific QNB 
binding obtained the absence of the tested molecules, or as lo3 x 
the ratio of the quantity of [3H]IPs (in d.p.m.) accumulated to the 
amount of [3H]inositol (in d.p.m.) taken up per cochlea (d.p.m. 
IPS X l@/d.p.m. inositol). The amount (d.p.m.) of [3H]inositol taken 
up per cochlea was measured in the flow-through fraction of anion- 
exchange chromatography as described elsewhere (Guiramand et al., 
1990). When not indicated, the data points are means f SEM of at 
least six replications. Controls of the basal IP metabolism, carbachol- 
induced IP formation and specific bound QNB were included in each 
replication. The statistical significance of the data was determined by 
one-way ANOVA. 
Results 
Effects of NEM and cadmium chloride on the synthesis of 
IPS 
Applications of either NEM or cadmium chloride do not change the 
basal metabolism of IPS at any concentration (Fig. 1). However, when 
the synthesis of IPS is stimulated by carbachol (1 mM), both 
sulphhydryl-rnodifjing reagents inhibited the formation of IPS in a dose- 
dependent manner. NEM is much more efficient than cadmium chloride 
in reducing the carbachol-induced accumulation of IPS (Fig. 1) since 
their respective IC,, values (concentrations of agents inhibiting 50% 
of the carbachol-induced IP accumulation) are 50 and 660 pM. The 
maximum inhibitions are obtained with NEM at 0.1 mM and cadmium 
chloride at 3 mM. 
Additive effects 
In these tests, ototoxins and sulphhydryl-modifying substances were 
used at concentrations smaller than the determined IC,, values (see 
above and Bartolami et al., 1993), except for NEM which was used 
at its IC,, and neomycin for which the IC,, was not determined. For 
each test of additivity, the data were compared to their linear additivity 
values. These theoretical values were calculated by subtracting, from 
the stimulated control level (effect of carbachol alone), the sums of 
the individual levels of inhibition provoked by each individual drug, 
when applied on its own. 
The addition of NEM at 50 pM to cisplatin (0.3 mM), mercuric 
chloride (3 pM) and neomycin (15 mM) results in a potentiation of 
the drug-elicited inhibitions of carbachol-induced synthesis of IPS (Fig. 
2). With these two drug combinations, the response levels are low, 
achieving values significantly smaller than their respective, linear 
additive values. When NEM and ethacrynic acid (0.3 nM) are 
combined, they display an additive inhibitory effect (Fig. 2; the gap 
between the linear additivity value and the experimental data is smaller 
than the SEM of the data). 
The combination of cadmium chloride (0.3 mM) with ethacrynate 
(0.3 nM) induces an additive inhibition of the carbachol-elicited 
accumulation of IPS (Fig. 2), whereas cadmium chloride does not 
potentiate the inhibitory effects of cisplatin (0.3 mM) and neomycin 
(15 mM). Indeed, the carbachol-induced synthesis of IPS reaches a level 
greater than the value of linear additivity for these combinations. When 
cadmium is associated with mercuric chloride (3 pM) a potentiation 
is observed since the IP response level is less than the value of linear 
additivity for the latter pair (Fig. 2). 
Effects of verapamil on cadmium chloride inhibition of the IP 
response 
Co-exposing the cochleas to both cadmium chloride ( 1  mM) and 
verapamil(1, 10 and 50 pM) causes a decrease in the level of inhibition 
in comparison to the magnitude of inhibition obtained when cadmium 
chloride is applied on its own (Fig. 3). Indeed, cadmium chloride 
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FIG. 2. Additivity tests between thiol modifier and ototoxins. Pairs of substances 
were applied to the cochleas prior to stimulation with 1 mM carbachol. Top, 
NEM and ototoxin combinations; bottom, cadmium and ototoxin combinations. 
The data are means f SEM of 6- 18 individual replications. The basal IP 
synthesis is 70 f 3 d.p.m. IPS x 10001d.p.m. inositol and the carbachol 
(1 mhl)-stimulated control level is 390 f 24 d.p.m. IPS X 1000/d.p.m. 
inositol. All the data differ from the stimulated control level at P < 0.01. NEM, 
N-ethylmaleimide; Cd, cadmium chloride; Eth, ethacrynate; CP, cisplatin; Hg, 
mercuric chloride; Neo, neomycin; TV, theoretical value of linear additivity. 
(1 mM) alone induces a 52 f 4 % mean inhibition of the carbachol- 
stimulated formation of IPS (P < 0.001), and the mean level of 
inhibition is reduced to 40 f 12% (P <0.01) by the addition of 1 pM 
verapamil. Combining cadmium with higher doses of verapamil 
increases the degree of protection of the muscarinic stimulation, with 
the mean cadmium block amounting to 12 f 15 and 33 f 11 X in 
the presence of 10 and 50 pM verapamil respectively. At these 
verapamil concentrations, the levels of accumulation of IPS are not 
statistically different from the IP response evoked by 1 mM carbachol 
(Fig. 3). The application of verapamil on its own (1, 10 and 50 pM) 
does not significantly alter the level of carbachol-induced synthesis of 
IPS (Fig. 3). 
0 
21 
FIG. 3. Effect of verapamil on the cadmium chloride-induced blockage of 
stimulated IP metabolism. The cochleas were treated with verapamil and 
cadmium chloride (1 mM) 15 min before beiig stimulated by carbachol(1 mM). 
The data are means f SEM of six individual replications. The basal IP synthesis 
(white bar) is 65 f 8 d.p.m. IPS X 1000/d.p.m. inositol, and the carbachol 
(1 mM)-stimulated control level (black bar) is 335 f 18 d.p.m. 
IPS x 10001d.p.m. inositol. Control, basal IP synthesis; carb, carbachol; Cd, 
cadmium chloride; Ve, verapamil. When not indicated, the effects of cadmium 
and/or verapamil are not statistically different from the carbachol (1 mM)- 
stimulated control level. 
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FIG. 4. Effects of DTNB and DL-dithiothrdtol on stimulated IP synthesis. The 
disulphide bridge altering-reagents were applied 15 min before the enhancement 
of IP metabolism by 1 mM carbachol. The results are means f SEM of 6-9 
individual replications. The basal IP synthesis is 62 f 4 d.p.m. 
IPS X 1000/d.p.m. inositol and the carbachol (1 mM)-stimulated control level 
is 268 f 35 d.p.m. IPS X 10001d.p.m. inositol. When error bar is not,indicated, 
the width of the error bar is smaller than the thickness of the symbols. Carb, 
carbachol. 
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FIG. 5. Effects of the sulphhydryl-modifying-reagents on specific QNB binding 
in cochlear homogenate. QNB at 0.08 nM was added, together with the thiol 
modifiers, to the membrane preparation diluted at 6 cochleas/ml. The results 
of each determination were obtained from duplicated experimental points. The 
presented data are means + SEM of three individual determinations and are 
given as percentages of the level of specific QNB binding obtained in the absence 
of thiol modifiers. This level is taken as 100% and is equal to 133 f 3 fmol 
QNB/mg of protein. Cd, cadmium. 
Effects of disulphide bond altering-molecules on the 
carbachol-stimulated synthesis of IPS 
Carbachol(1 mM)-activated IP metabolism is not significantly changed 
by either DL-dithiothreitol (from 0.1 pM to 10 mM) or DTNB (from 
1 pM to 10 mM, Fig. 4). 
Effects of NEM and cadmium chloride on QNB binding 
Neither NEM (10 pM, 50 pM and 0.1 mM) nor cadmium chloride 
(30 pM ,0.3 mM and 3 mM) have a significant effect on the specific 
binding of QNB (Fig. 5). In this set of experiments the mean specific 
QNB binding with the cochlear membranes is 133 + 13 (+ SEM) fmol 
QNB/mg protein or 0.90 f 0.09 fmol QNB/cochlea. The effects of 
the disulphide bond-altering molecules DTNB and DL-dithiothreitol on 
QNB binding were not tested because of their failure to modify the 
carbachol-evoked IP response. 
Discussion 
In the 12-day-old cochlea, NEM and cadmium do not alter the basal 
metabolism of IPS but they block the turnover of IPS activated via 
muscarinic receptors. Their effects are not mediated by a direct action 
at the binding site of the cochlear muscarinic receptor, an observation 
that is in agreement with reports stating that NEM does not displace 
the QNB binding in rat brain (Carson, 1980; Korn et al., 1983). Unlike 
the inhibitory effects of cadmium and NEM, pretreatments with the 
disulphide bond reagents DTNB and DL-dithiothreitol do not affect the 
carbachol-stimulated synthesis of IPS. The lack of effect of these 
compounds suggests that the muscarinic receptor-coupled IP turnover 
is either resistant to these molecules or that destruction of disulphide 
bonds (DL-dithiothreitol) and induction of disulphide bonds (DTNB) 
do not affect this cochlear signalling pathway. This is supported by 
observations showing that DTNB has no effect on muscarinic binding 
in rat brain (Carson, 1980) and that DL-dithiothreitol does not alter 
carbachol-induced formation of IPS in 8-day-old rat brain 
synaptoneurosomes (Vignes et al., 1992). Simultaneous exposure of 
cochleas to ototoxins and N-ethylmaleimide or cadmium indicates that 
NEM acts synergistically with all ototoxins except ethacrynate to inhibit 
the carbachol stimulation. Conversely cadmium expresses synergism 
only with mercury but it does not potentiate the effect of cisplatin and 
neomycin. Synergism between thiol modifiers and neomycin, cisplatin 
and mercury indicate that the compounds may act on different targets 
in the signalling pathway, as shown by the fact that these three ototoxins 
block QNB binding ( S .  Bartolami, M. Planche and R. Pujol, submit- 
ted for publication) while the thiol modifiers do not affect muscarinic 
binding sites (Fig. 5). Interestingly, both cadmium and NEM induce 
additive inhibitions of the IP responses with ethacrynate, indicating 
that they may strike common targets. 
Concerning cadmium, the possibility that it reduces the metabolism 
of IPS by blocking calcium influx (Tsien, 1983) should be considered 
since phospholipase C ,  which hydrolyses the membrane 
phosphoinositides into IPS, is sensitive to cytosolic calcium (Crooke 
and Bennett, 1989). However, the application of verapamil, an 
antagonist of voltage-sensitive calcium channels, does not significantly 
change the carbachol-induced synthesis of IPS in the rat cochlea. 
Therefore, assuming that all calcium channels are not closed, inhibition 
of phospholipase C via a decrease in calcium permeability may not 
be involved in the cadmium effect. Interestingly, cadmium and 
verapamil when co-applied decrease the level of inhibition of the 
carbachol stimulation, with respect to the one measured in the case 
of the cadmium exposure. Cadmium toxicity in GH,C, cells is 
blocked by voltage-gated calcium channel antagonists, including 
verapamil (Hinkle et al., 1987). These authors demonstrated that this 
toxicity developed in cells following the entry of cadmium through 
voltage-sensitive calcium channels. Therefore, calcium channel blockers 
protect the cells by decreasing the influx of cadmium through calcium 
channels. Consequently, this may explain why cadmium does not 
potentiate the inhibitory effects of either neomycin or cisplatin, since 
aminoglycosides and cisplatin block voltage-sensitive calcium channels 
(Dulon et al., 1989; Saito et al.,  1991). 
The block of the cochlear IP signalling pathway associated with 
cholinergic stimulation by NEM and cadmium may involve interactions 
with M3 muscarinic receptors, guanine nucleotide binding proteins (G 
proteins) and phospholipase C enzymes. Whatever the proteins 
involved, it is possible that cadmium and NEM may react preferentially 
with cysteine residues. 
The M3 muscarinic receptors 
Although muscarinic binding sites are not affected by NEM and 
cadmium, these molecules may interact with intracellular regions of 
the receptors. The sequence of the cloned rat m3 receptor, 
corresponding to the M3 pharmacological type, contains 13 cysteines 
(Bonner, 1989). Amongst them, three residues are located in the third 
intracellular loop, which is involved in the interaction with G proteins 
(Bonner, 1992). It is possible that the blockage of the thiol group of 
these cysteines may impede receptor -G protein coupling. Indeed, 
NEM has been shown to interfere with this coupling reaction in the 
rat brain (Korn et al.,  1983) and other systems (Harden et al., 1982). 
The G proteins 
In the cochlea, Gt, Gs, Gi and Go proteins are presumably present 
(Canlon et al., 1991; Koch and Gloddek, 1991; Tachibana et al., 
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1992), but Gp or Gq proteins, which activate phospholipase C in various 
systems (Ashkenazi et al., 1989; Strathmann and Simon, 1990; Taylor 
et al., 1991; Smrcka et al., 1991), have not been detected yet. Anyway, 
whatever the type of G protein associated with the activation of the 
signalling pathway, one can hypothesize that cysteine residues of G 
proteins may be targets for cadmium and/or NEM. This idea is based 
on the observation that complexation by NEM of two cysteines of the 
alpha subunits of Go proteins results in inhibition of its GTPase activity 
(Winslow et al., 1987). In addition, a conserved cysteine has been 
located in the 20 residue C-terminal segment of the alpha chain of Gi, 
Go and Gt proteins. The blockage of this cysteine may have drastic 
effects on the transduction system since the 20 amino acid segment 
is a contact site involved in G protein-receptor coupling (Sullivan 
et al., 1987). Finally, the uncoupling effect of NEM, due to blockage 
of G proteins, has been evidenced in many systems (Harden et al., 
1982; Aronstam and Carrier, 1982; Korn et al., 1983; Northup et al., 
1983; Winslow et al., 1987; Freeman and Lau, 1991). 
The phospholipase C enzymes 
At least seven types of phospholipase C isozymes have been isolated, 
but none of them from the cochlea. The amino acid sequences were 
deduced from cDNA clones of four isozymes (Crooke and Bennet, 
1989; Rhee et al., 1989). The analysis of these sequences reveals that 
cysteines are present in the catalytic regions of all isozymes (Crooke 
and Bennet, 1989). This makes phospholipase C an additional putative 
target for NEM and/or cadmium. However, in cochleas exposed to 
both substances, no change in the basal IP turnover is obtained, 
therefore inhibition by NEM or cadmium due to a direct action on 
phospholipase C must be dismissed. 
Implication in ototoxin effects 
Concerning the mechanisms of ototoxin inhibition of the carbachol- 
induced IP response, previous observations suggest that neomycin may 
act by suppressing the supply of substrate to phospholipase C (Schacht, 
1976, 1986), and both mercury and cisplatin may inhibit 
agonist -muscarink receptor binding (Bartolami et al. ,  1993). New 
information based on the present NEM effects sheds more light on the 
mechanism of action of ethacrynate on the stimulated IP response. 
Indeed, NEM, like ethacrynate, inhibits the carbachol effect but does 
not inhibit the QNB binding. Furthermore, NEM and ethacrynate block 
stimulated IP formation in an additive way, indicating that NEM and 
ethacrynate share the same target within the transduction system. Since 
NEM suppresses G protein activity and ethacrynate has been proposed 
to behave similarly in the cochlea (Koch and Gloddek, 1991), and since 
they interact similarly with the muscarinic receptor-coupled IP turnover, 
it is possible that ethacrynate diminishes carbachol-induced IP synthesis 
by uncoupling phospholipases C from cholinoceptors via a direct action 
on G proteins. 
Conclusions 
The reported data show that cadmium and NEM inhibit in vitro the 
synthesis of IPS activated via the stimulation of M3 cholinoceptors in 
the 12-day-old rat cochlea. The mechanisms of the inhibitory action 
of N-ethylmaleimide and cadmium seem to be different from those of 
the suppressing effects of neomycin, cisplatin and mercury. Conversely, 
ethacrynate and thiol modifiers, having identical inhibitory features, 
appear to react with the same targets, possibly the G proteins. 
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Abbreviations 
DTNB 5,5’-dithio-bis-2-nitrobenzoic acid 
HEPES N-(2-hydroxyethyl)piperazine-N‘-(2-ethanesulphonic acid) 
IC,, 50% inhibitory concentration 
IP inositol phosphate 
OHC outer hair cell 
PBS phosphate-buffered saline 
NEM N-ethylmaleimide 
QNB quiniclidinyl benzylate 
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